Inflexion, a leading European mid-market private equity firm, is pleased to announce that L'Oréal Groupe has agreed to acquire a majority shareholding in premium British skincare brand, Medik8. The partnership with L'Oréal will allow Medik8 to deepen its presence in existing markets and expand globally. As part of the transaction, Inflexion will retain a minority shareholding in Medik8.
Founded in 2009 by British scientist Elliot Isaacs, Medik8 is a premium clinical skincare brand, offering high-quality active skincare products which deliver clinical results without compromising on experience. Best known for its iconic Crystal Retinal serum and its trademark CSA Philosophy®, Vitamin C and Sunscreen by Day, Vitamin A by night, Medik8 formulates and manufactures its products in-house in its UK Innovation Centre.
During Inflexion’s four-year investment, Medik8 has achieved significant global growth, tripling both its headcount and sales, expanding across Europe, Australia, and notably strengthening its US presence with US revenue share increasing sevenfold. With Inflexion’s backing, the brand has enhanced its digital capabilities, driving a six-times increase in direct-to-consumer sales, and opened a 100,000 sq. ft. Innovation Centre. Launched within the first year of partnership, the new site helped triple R&D and operational capacity, ultimately contributing to the successful launch of several award-winning products in that time frame, including Liquid Peptides Advanced MP. Significant investment in organisational design saw the appointment of a Chair, CEO, CPO and CMO and new roles in digital, data, innovation and sustainability with Medik8 achieving B Corp™ certification in 2024, underscoring its commitment to sustainability.
This is an exciting day for our brand. With the support of Inflexion, we’ve shown Medik8 to be a formidable force, powered by high-quality, clinically proven results without compromise. We now enter our next phase of growth, with L’Oreal’s support, enabling us to further strengthen our innovation capabilities and reach even more customers worldwide.
Medik8 enters a new era today. Backed by Inflexion, we grew faster and stronger – not by diluting our founding values, but by doubling down on them. I’m proud to see Medik8 join with L’Oréal a strategic partner that shares our unwavering commitment to science, innovation and above all, results without compromise.
Medik8 has all the hallmarks of a classic Inflexion investment – a close partnership with founders and management to drive long-term, sustainable growth. We are proud to have helped accelerate Medik8’s journey into a leading global skincare brand.
Medik8 has always been such a unique and differentiated business, with a brilliant product-led culture. When we invested, we could see how much potential it had, and I’m extremely proud of what we have achieved together. Working with the whole team has been a true privilege, and I am delighted we will remain involved alongside L’Oréal in this next chapter.
Contact us
Please contact us if you have any media enquiries
